<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35149529</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1550-6606</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>208</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
          <ISOAbbreviation>J Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent <i>Francisella tularensis</i>.</ArticleTitle>
        <Pagination>
          <StartPage>1180</StartPage>
          <EndPage>1188</EndPage>
          <MedlinePgn>1180-1188</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.2100915</ELocationID>
        <Abstract>
          <AbstractText>Pulmonary infections elicit a combination of tissue-resident and circulating T cell responses. Understanding the contribution of these anatomically distinct cellular pools in protective immune responses is critical for vaccine development. <i>Francisella tularensis</i> is a highly virulent bacterium capable of causing lethal systemic disease following pulmonary infection for which there is no currently licensed vaccine. Although T cells are required for survival of <i>F. tularensis</i> infection, the relative contribution of tissue-resident and circulating T cells is not completely understood, hampering design of effective, long-lasting vaccines directed against this bacterium. We have previously shown that resident T cells were not sufficient to protect against <i>F. tularensis</i>, suggesting circulating cells may serve a critical role in host defense. To elucidate the role of circulating T cells, we used a model of vaccination and challenge of parabiotic mice. Intranasally infected naive mice conjoined to immune animals had increased numbers of circulating memory T cells and similar splenic bacterial burdens as vaccinated-vaccinated pairs. However, bacterial loads in the lungs of naive parabionts were significantly greater than those observed in vaccinated-vaccinated pairs, but despite early control of <i>F. tularensis</i> replication, all naive-vaccinated pairs succumbed to infection. Together, these data define the specific roles of circulating and resident T cells in defense against infection that is initiated in the pulmonary compartment but ultimately causes disseminated disease. These data also provide evidence for employing vaccination strategies that elicit both pools of T cells for immunity against <i>F. tularensis</i> and may be a common theme for other disseminating bacterial infections.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Roberts</LastName>
            <ForeName>Lydia M</ForeName>
            <Initials>LM</Initials>
            <AffiliationInfo>
              <Affiliation>Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT; and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wehrly</LastName>
            <ForeName>Tara D</ForeName>
            <Initials>TD</Initials>
            <AffiliationInfo>
              <Affiliation>Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT; and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leighton</LastName>
            <ForeName>Ian</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT; and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hanley</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-2300-1818</Identifier>
            <AffiliationInfo>
              <Affiliation>Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lovaglio</LastName>
            <ForeName>Jamie</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-7567-446X</Identifier>
            <AffiliationInfo>
              <Affiliation>Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Brian J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bosio</LastName>
            <ForeName>Catharine M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT; and bosioc@niaid.nih.gov.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Z01 AI001013</GrantID>
            <Acronym>ImNIH</Acronym>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Immunol</MedlineTA>
        <NlmUniqueID>2985117R</NlmUniqueID>
        <ISSNLinking>0022-1767</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001428">Bacterial Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.48</RegistryNumber>
          <NameOfSubstance UI="D017493">Leukocyte Common Antigens</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.48</RegistryNumber>
          <NameOfSubstance UI="C516770">Ptprc protein, mouse</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058491" MajorTopicYN="N">Bacterial Load</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001428" MajorTopicYN="N">Bacterial Vaccines</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005604" MajorTopicYN="N">Francisella tularensis</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017493" MajorTopicYN="N">Leukocyte Common Antigens</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000091246" MajorTopicYN="N">Memory T Cells</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014406" MajorTopicYN="N">Tularemia</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>3</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>5</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35149529</ArticleId>
        <ArticleId IdType="mid">NIHMS1768123</ArticleId>
        <ArticleId IdType="pmc">PMC8881340</ArticleId>
        <ArticleId IdType="doi">10.4049/jimmunol.2100915</ArticleId>
        <ArticleId IdType="pii">jimmunol.2100915</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, and Carhart S, Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med, 1961. 107: p. 702–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13746667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gill V and Cunha BA, Tularemia pneumonia. Semin Respir Infect, 1997. 12(1): p. 61–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9097380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>European Centre for Disease Prevention and Control. Tularaemia Annual Epidemiological Report for 2019. 2021; Available from: https://www.ecdc.europa.eu/sites/default/files/documents/AER-tularaemia-2019.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Tularemia. 2021; Available from: https://www.cdc.gov/tularemia/index.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Alibek K and Handelman S, Biohazard: the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it. 1st Ed ed. 1999, New York: Random House.</Citation>
        </Reference>
        <Reference>
          <Citation>Christopher GW, Cieslak TJ, Pavlin JA, and Eitzen EM Jr., Biological warfare. A historical perspective. JAMA, 1997. 278(5): p. 412–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9244333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eigelsbach HT and Downs CM, Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J Immunol, 1961. 87: p. 415–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13889609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burke DS, Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis, 1977. 135(1): p. 55–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">833449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrumb FR, Aerosol Infection of Man with Pasteurella Tularensis. Bacteriol Rev, 1961. 25(3): p. 262–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC441102</ArticleId>
            <ArticleId IdType="pubmed">16350172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saslaw S, Eigelsbach HT, Wilson HE, Prior JA, and Carhart S, Tularemia vaccine study. I. Intracutaneous challenge. Arch Intern Med, 1961. 107: p. 689–701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13746668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, KuoLee R, Shen H, and Conlan JW, Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. Microb Pathog, 2004. 36(6): p. 311–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15120157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conlan WJ, Shen H, Kuolee R, Zhao X, and Chen W, Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism. Vaccine, 2005. 23(19): p. 2477–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15752834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crane DD, Scott DP, and Bosio CM, Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS One, 2012. 7(3): p. e33349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3299770</ArticleId>
            <ArticleId IdType="pubmed">22428026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts LM, Crane DD, Wehrly TD, Fletcher JR, Jones BD, and Bosio CM, Inclusion of Epitopes That Expand High-Avidity CD4+ T Cells Transforms Subprotective Vaccines to Efficacious Immunogens against Virulent Francisella tularensis. J Immunol, 2016. 197(7): p. 2738–2747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5026927</ArticleId>
            <ArticleId IdType="pubmed">27543611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yee D, Rhinehart-Jones TR, and Elkins KL, Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol, 1996. 157(11): p. 5042–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8943413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, and Lyons CR, Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun, 2005. 73(5): p. 2644–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1087315</ArticleId>
            <ArticleId IdType="pubmed">15845466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slutter B, Van Braeckel-Budimir N, Abboud G, Varga SM, Salek-Ardakani S, and Harty JT, Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity. Sci Immunol, 2017. 2(7).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5590757</ArticleId>
            <ArticleId IdType="pubmed">28783666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilk MM, Misiak A, McManus RM, Allen AC, Lynch MA, and Mills KHG, Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis. J Immunol, 2017. 199(1): p. 233–243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28533445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zens KD, Chen JK, and Farber DL, Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection. JCI Insight, 2016. 1(10).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4959801</ArticleId>
            <ArticleId IdType="pubmed">27468427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao J, Zhao J, Mangalam AK, Channappanavar R, Fett C, Meyerholz DK, Agnihothram S, Baric RS, David CS, and Perlman S, Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses. Immunity, 2016. 44(6): p. 1379–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4917442</ArticleId>
            <ArticleId IdType="pubmed">27287409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts LM, Wehrly TD, Ireland RM, Crane DD, Scott DP, and Bosio CM, Temporal Requirement for Pulmonary Resident and Circulating T Cells during Virulent Francisella tularensis Infection. J Immunol, 2018. 201(4): p. 1186–1193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6086594</ArticleId>
            <ArticleId IdType="pubmed">29980611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson RV, Crane DD, and Bosio CM, Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine, 2010. 28(40): p. 6562–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2939155</ArticleId>
            <ArticleId IdType="pubmed">20688042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griffin AJ, Crane DD, Wehrly TD, and Bosio CM, Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells. Clin Vaccine Immunol, 2015. 22(1): p. 119–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4278928</ArticleId>
            <ArticleId IdType="pubmed">25410207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jessop F, Buntyn R, Schwarz B, Wehrly T, Scott D, and Bosio CM, Interferon Gamma Reprograms Host Mitochondrial Metabolism through Inhibition of Complex II To Control Intracellular Bacterial Replication. Infect Immun, 2020. 88(2).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6977132</ArticleId>
            <ArticleId IdType="pubmed">31740527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fortier AH, Slayter MV, Ziemba R, Meltzer MS, and Nacy CA, Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect Immun, 1991. 59(9): p. 2922–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC258114</ArticleId>
            <ArticleId IdType="pubmed">1879918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woolard MD, Hensley LL, Kawula TH, and Frelinger JA, Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect Immun, 2008. 76(6): p. 2651–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2423094</ArticleId>
            <ArticleId IdType="pubmed">18391003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horzempa J, O’Dee DM, Stolz DB, Franks JM, Clay D, and Nau GJ, Invasion of Erythrocytes by Francisella tularensis. Journal of Infectious Diseases, 2011. 204(1): p. 51–59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3105038</ArticleId>
            <ArticleId IdType="pubmed">21628658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirimanjeswara GS, Golden JM, Bakshi CS, and Metzger DW, Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol, 2007. 179(1): p. 532–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17579074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole LE, Mann BJ, Shirey KA, Richard K, Yang Y, Gearhart PJ, Chesko KL, Viscardi RM, and Vogel SN, Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge. J Leukoc Biol, 2011. 90(4): p. 787–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3177696</ArticleId>
            <ArticleId IdType="pubmed">21750122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stefanetti G, Okan N, Fink A, Gardner E, and Kasper DL, Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis. Proc Natl Acad Sci U S A, 2019. 116(14): p. 7062–7070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6452683</ArticleId>
            <ArticleId IdType="pubmed">30872471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savitt AG, Mena-Taboada P, Monsalve G, and Benach JL, Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy. Clin Vaccine Immunol, 2009. 16(3): p. 414–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2650858</ArticleId>
            <ArticleId IdType="pubmed">19176692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allie SR, Bradley JE, Mudunuru U, Schultz MD, Graf BA, Lund FE, and Randall TD, The establishment of resident memory B cells in the lung requires local antigen encounter. Nat Immunol, 2019. 20(1): p. 97–108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6392030</ArticleId>
            <ArticleId IdType="pubmed">30510223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wijeyesinghe S, Beura LK, Pierson MJ, Stolley JM, Adam OA, Ruscher R, Steinert EM, Rosato PC, Vezys V, and Masopust D, Expansible residence decentralizes immune homeostasis. Nature, 2021. 592(7854): p. 457–462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8057530</ArticleId>
            <ArticleId IdType="pubmed">33731934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glennie ND, Yeramilli VA, Beiting DP, Volk SW, Weaver CT, and Scott P, Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. J Exp Med, 2015. 212(9): p. 1405–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4548053</ArticleId>
            <ArticleId IdType="pubmed">26216123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bar-Haim E, Gat O, Markel G, Cohen H, Shafferman A, and Velan B, Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection. PLoS Pathog, 2008. 4(11): p. e1000211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2582141</ArticleId>
            <ArticleId IdType="pubmed">19023422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosio CM, Bielefeldt-Ohmann H, and Belisle JT, Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol, 2007. 178(7): p. 4538–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17372012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forestal CA, Malik M, Catlett SV, Savitt AG, Benach JL, Sellati TJ, and Furie MB, Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis, 2007. 196(1): p. 134–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17538893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ojeda SS, Wang ZJ, Mares CA, Chang TA, Li Q, Morris EG, Jerabek PA, and Teale JM, Rapid dissemination of Francisella tularensis and the effect of route of infection. BMC Microbiol, 2008. 8: p. 215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2651876</ArticleId>
            <ArticleId IdType="pubmed">19068128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, Brown W, Le M, Berggren R, Parks WT, and Fang FC, Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature, 1999. 401(6755): p. 804–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10548107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodero MP, Poupel L, Loyher PL, Hamon P, Licata F, Pessel C, Hume DA, Combadiere C, and Boissonnas A, Immune surveillance of the lung by migrating tissue monocytes. Elife, 2015. 4: p. e07847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4521583</ArticleId>
            <ArticleId IdType="pubmed">26167653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daley-Bauer LP, Roback LJ, Wynn GM, and Mocarski ES, Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microbe, 2014. 15(3): p. 351–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3989205</ArticleId>
            <ArticleId IdType="pubmed">24629341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE, Pang YS, Graham BS, Lowy DR, and Schiller JT, A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8(+) Memory T Cells . J Immunol, 2019. 202(4): p. 1250–1264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6391875</ArticleId>
            <ArticleId IdType="pubmed">30635393</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
